Abbott Laboratories 2012 Annual Report Download - page 14

Download and view the complete annual report

Please find page 14 of the 2012 Abbott Laboratories annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 68

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68

For cataracts, Abbott offers lens removal systems, viscoelastics and
intraocular lenses (IOLs) that deliver improved functional vision by reducing
image blur caused by refractive error, and multifocal IOLs that significantly
reduce or eliminate the need for eyeglasses. Finally, our contact-lens cleaning
systems provide powerful disinfection capabilities, and are recommended by
physicians for safe, effective contact-lens cleaning. Abbott’s lubricating eye
drops provide long-lasting relief for those who suffer from eye symptoms.
A Wide-Ranging Presence in Diagnostics
In diagnostics, Abbott is well positioned, with global leadership in in vitro
diagnostics, which includes immunoassay, clinical chemistry, hematology,
molecular, point of care, and informatics. In its largest segment of the
market, core laboratory and blood screening, Abbott offers a broad range
of innovative instrument systems and tests, as well as informatics and
automation solutions for hospitals, reference labs, blood banks, physician
offices and clinics. Our advanced diagnostic solutions provide early, accurate
diagnosis and management of many medical conditions including cardiac
disease, diabetes, and infectious disease.
Our Architect modular analyzers provide immunoassay and clinical
chemistry results for cardiac disease, cancer, endocrinology, fertility,
infectious disease and other conditions. The Cell-Dyn series, which is our
premier hematology system, is used to perform sophisticated blood cell
analysis for several blood diseases and disorders. And our fully-automated
Prism blood-screening system consolidates high-volume testing into a single
system, reducing the risk of accidents and errors and helping to ensure the
safety of the blood supply.
Molecular and point-of-care systems round out our diagnostic offerings.
Abbott is a leader in the rapidly growing area of molecular diagnostics and
the advancing field of personalized medicine. Our tests are designed to detect
subtle, but key, differences in patients’ genes and chromosomes, which can
assist physicians in the identification of disease, the selection of appropriate
therapies and the monitoring of conditions. Abbott point-of-care products
provide healthcare professionals immediate access to accurate, critical
diagnostic test results at the point of patient care. Our i-STAT hand-held
analyzer, the industry’s leading point-of-care system, lets physicians make
treatment decisions at the patient’s bedside, speeding care in emergency
departments, operating rooms, and critical care units.
Today’s Abbott
Architect
Laboratory Diagnostics
12
Abbott 2012 Annual Report